Sign in
CompletedNo phase

Brain Injury Outcomes (BIO) Study

Key facts

Who runs it
VA Office of Research and Development
Where
Washington D.C., United StatesSee the site
Trial code
Status
Completed
People taking part
91 people enrolled
Started
6 May 2008
Ended
15 Jan 2024
Type of study
Observational, 3 groups
Record updated
18 June 2024

Who can take part

Age
18 years to 59 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 26 criteriaShow less

Who can take part

  • TBI group Veterans must:
  • be enrolled at the Washington, DC VA Medical Center
  • be an Operation Enduring Freedom (OEF)/ Operation Iraqi Freedom (OIF)/OND Veteran
  • be between the ages of 18 and 59, inclusive
  • have at least 10 years of education
  • be able to fit into scanner (i.e., weigh less than 400 pounds)
  • have a brain injury (based upon VHA criteria)
  • be at least one year post-injury
  • NonTBI group Veterans must:
  • be enrolled at the Washington, DC VAMC
  • have been active duty (whether deployed or not) during OEF and/or OIF and/or OND
  • be between the ages of 18 and 59, inclusive
  • have at least 10 years of education

Who cannot take part

  • have had or currently have any other injury, medical or neurological illness, or exposure that could potentially explain cognitive deficits (e.g., Central Nervous System disease, prior brain injury, seizure disorder, or HIV)
  • be taking prescription drugs that significantly interfere with outcome measures
  • be colorblind or have any visual impairment that interferes with reading or writing
  • have a current acute or unstable psychiatric condition
  • have a current diagnosis (or symptoms consistent with) schizophrenic or bipolar disorders, or severe uni-polar depression
  • have a diagnosis of diabetes (PET imaging considerations)
  • Veterans must NOT:
  • have any upper extremity dysfunction that prevents the use of a pencil or computer mouse or keyboard
  • meet criteria for substance dependence within 1 month of the evaluation
  • be in significant pain during the evaluation (patient subjective report)
  • have any devices or material implanted, embedded, or attached to the body containing ferrous material that interferes with MR imaging (i.e., pacemaker, shrapnel)
  • Be a pregnant or lactating female (MRI considerations)
  • Display behavior that would significantly interfere with validity of data collection or safety during study

Where in United States

  • Washington DC VA Medical Center, Washington, DCWashington D.C., United States

About the trial

What the trial wants to find out

Many active duty military, national guard, and reserves personnel who served in the recent conflicts in Afghanistan and Iraq were exposed to blasts and other mechanisms of traumatic brain injury (TBI).1,2 Although physical trauma is not unexpected during war fighting, survival after head injury, particularly blast-related, has become a common occurrence only in recent decades. As such, the associated cerebral damage is less well studied and understood, particularly over the long term.

Read full original descriptionShow less

The Brain Injury Outcomes (BIO) is a longitudinal study with the short-term objective of better characterizing multi-modal outcomes in individuals who have sustained a brain injury using a systems medicine approach. Long-term aims include monitoring participants for signs of emerging symptoms or age-related vulnerabilities. Identification of abnormality profiles for multiple severity levels of brain injury (from any source, including blast and non-blast) reflects a second long-range goal. Third, the investigators will examine and compare physiology between Veterans who have sustained a Mild Traumatic Brain Injury (mTBI) with and without persisting symptoms and various co-morbidities including posttraumatic stress disorder (PTSD) and depression. A control group of Veterans who have not sustained a TBI will also be recruited for comparison. Fourth, the investigators intend to facilitate the clinical use of advanced methodologies, such as brain imaging measures, with the brain injured (and other populations). Finally, the investigators will assess methods of analysis, separately and in combination through integration, for multi-modal data in search of diagnostic profiles. Increased knowledge of injury patterns and the trajectory associated with brain injury could contribute to better methods of diagnosis, monitoring and, perhaps, treatment.

This investigation has spawned several sub-studies, one of which was the Validation of Brief Objective Neurobehavioral Detectors (BOND) of Mild TBI, which continues. The investigators have collaborated with Harvard/Boston Children's Hospital in the Angiogenic Signaling Signatures Identified in Stress and Trauma (ASSIST) sub-study. Oak Ridge National Laboratory (ORNL) will assist in integrating BIO Study multi-modal data. Investigators at Johns Hopkins School of Medicine collaborate with neuroimaging sequences and methods.

The 3 groups in the trial

  • TBI (Case) Group

    Members of the TBI group have sustained a TBI in accordance with inclusion/exclusion criteria. However, the investigative staff administering, scoring, analyzing and interpreting the data will be blinded to the group status of the participant.

  • Non-TBI (Control) Group

    Members of the Non-TBI group have not sustained a TBI and are in accordance with other provisions of the inclusion/exclusion criteria. However, the investigative staff administering, scoring, analyzing and interpreting the data will be blinded to the group status of the participant. This longitudinal study will utilize a control group to account for normal aging and other control factors.

  • Non-TBI Non-deployed (Control) Group

    Members of the Non-TBI Non-Deployed group have neither sustained a TBI nor have been deployed but are in accordance with other provisions of the inclusion/exclusion criteria. However, the investigative staff administering, scoring, analyzing and interpreting the data will be blinded to the group status of the participant. This longitudinal study will utilize this Non-deployed control group to account for deployment-specific factors.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Validation of Brief Objective Neurobehavioral Detectors of Mild TBI
Record updated
18 June 2024